Meta Pixel

News and Announcements

ChimpChange Growth Supercharged By U.S. Tax Season

  • Published April 26, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Australia’s only listed digital banking platform, ChimpChange, has posted strong organic growth supercharged by the U.S. tax refund season.

INVESTMENT HIGHLIGHTS

  • Strong trading quarter delivers key revenue milestone ahead of target
  • Doubling of key metrics quarter on quarter ~ Transaction Volume (“TTV”),
  • Customer Deposits, Customer Spend, and Revenue to new highs
  • In excess of 18,000 new banking customers during the quarter
  • Annualised TTV run-rate of US$118 million (A$155 million1) up from A$56 million in
  • the previous quarter
  • New Savings Account with round-up feature launched in April following
  • successful pilot during the quarter
  • Significant progress in build-out of internal processing capabilities delivering
  • improved costs and faster to market innovation of neo-banking functionality and product.

Ash Shilkin, Founder and Managing Director of ChimpChange, stated:

“We continued to aggressively scale our business model resulting in the Company more than doubling total revenues compared to the previous quarter and achieving an A$1 million revenue run rate ahead of forecast.

“Furthermore, we finished the March quarter with TTV running at an annualised run rate in excess of US$118 million (A$155 million1), strongly up from US$56 million at the end of the December quarter.

“We are tremendously gratified that so many people choose to bank with ChimpChange and trust our platform with their daily banking needs, reinforcing our investment and drive in the ChimpChange banking proposition.”

To download the full report, please click on the link to the left. 

Request Offer

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now